Voya Investment Management LLC Esperion Therapeutics, Inc. Transaction History

Voya Investment Management LLC

  • $79.9 Billion
  • Q3 2024

A detailed history of Voya Investment Management LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 63,142 shares of ESPR stock, worth $145,226. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63,142
Previous 63,029 0.18%
Holding current value
$145,226
Previous $139,000 25.18%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1.61 - $2.73 $181 - $308
113 Added 0.18%
63,142 $104,000
Q2 2024

Dec 03, 2024
SELL
$1.84 - $3.24 $207 - $366
-113 Reduced 0.18%
63,029 $139,000
Q2 2024

Aug 14, 2024
BUY
$1.84 - $3.24 $115,973 - $204,213
63,029 New
63,029 $139,000
Q4 2022

Feb 14, 2023
BUY
$5.09 - $8.5 $7,706 - $12,869
1,514 Added 5.71%
28,043 $174,000
Q3 2022

Mar 03, 2023
SELL
$5.45 - $8.13 $8,251 - $12,308
-1,514 Reduced 5.4%
26,529 $177,000
Q3 2022

Nov 14, 2022
BUY
$5.45 - $8.13 $11,673 - $17,414
2,142 Added 8.78%
26,529 $178,000
Q2 2022

Aug 15, 2022
SELL
$4.77 - $6.67 $109,938 - $153,730
-23,048 Reduced 48.59%
24,387 $155,000
Q1 2022

May 16, 2022
BUY
$3.34 - $5.56 $158,432 - $263,738
47,435 New
47,435 $220,000
Q4 2021

Feb 14, 2022
SELL
$4.81 - $11.92 $50,952 - $126,268
-10,593 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$19.4 - $28.71 $23,027 - $34,078
-1,187 Reduced 10.08%
10,593 $224,000
Q1 2021

May 17, 2021
BUY
$25.12 - $36.89 $15,674 - $23,019
624 Added 5.59%
11,780 $330,000
Q4 2020

Feb 16, 2021
BUY
$24.2 - $35.76 $54,377 - $80,352
2,247 Added 25.22%
11,156 $290,000
Q2 2020

Aug 14, 2020
SELL
$30.04 - $51.31 $111,148 - $189,847
-3,700 Reduced 29.34%
8,909 $457,000
Q1 2020

May 15, 2020
BUY
$27.44 - $73.84 $9,521 - $25,622
347 Added 2.83%
12,609 $398,000
Q4 2019

Feb 14, 2020
BUY
$35.4 - $59.82 $89,809 - $151,763
2,537 Added 26.09%
12,262 $731,000
Q2 2019

Aug 14, 2019
BUY
$40.1 - $52.33 $10,987 - $14,338
274 Added 2.9%
9,725 $452,000
Q4 2018

Feb 14, 2019
SELL
$36.99 - $59.11 $3.83 Million - $6.11 Million
-103,437 Reduced 91.63%
9,451 $435,000
Q3 2018

Nov 14, 2018
SELL
$40.74 - $51.41 $11.7 Million - $14.8 Million
-287,925 Reduced 71.84%
112,888 $5.01 Million
Q2 2018

Aug 14, 2018
BUY
$36.2 - $76.4 $3.02 Million - $6.38 Million
83,551 Added 26.34%
400,813 $15.7 Million
Q1 2018

May 15, 2018
BUY
$65.94 - $80.76 $20.4 Million - $25 Million
309,589 Added 4034.78%
317,262 $22.9 Million
Q3 2017

Nov 14, 2017
BUY
$43.8 - $52.77 $336,077 - $404,904
7,673
7,673 $385,000

Others Institutions Holding ESPR

# of Institutions
206
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $153M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email